About this role
<div><div style="padding:10.0px 0.0px;border:1.0px solid transparent"><div style="font-size:16.0px;word-wrap:break-word"><H2 style="font-size:1.0em;margin:0.0px">Qualification and Experience</H2> </div><div><ul> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Bachelor’s degree in Life Sciences or Business; MBA or equivalent preferred.</span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">12+ years of progressive commercial experience in generics, biosimilars, and/or 505(b)(2) pharmaceuticals.</span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Deep understanding of the U.S. payer and provider landscape.</span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Ability to navigate regulatory nuances specific to generics and hybrid pathways. </span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Executive presence and a history of leading high-performing commercial teams. </span></li> </ul> <p><span style="font-family:arial, helvetica, sans-serif"><strong>Preferred Attributes:</strong></span></p> <ul> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Experience with digital marketing and data-driven decision-making. </span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Familiarity with 340B, 505B2, GPOs, and institutional customer segments. </span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Ability to navigate ambiguity and drive results in a competitive market.</span></li> <li style="font-family:arial, helvetica, sans-serif"><span style="font-family:arial, helvetica, sans-serif">Demonstrated success in launching and optimizing performance for complex assets.</span></li> </ul> <p style="font-family:arial, helvetica, sans-serif"> </p> <p style="margin:0.0in;font-family:Arial;font-size:10.0pt"><span style="font-size:12.0pt;font-family:arial, helvetica, sans-serif">The anticipated annual base salary range for this position in<span style="font-weight:bold"> </span>New Jersey is $300,000 to $3500,000 base, plus a discretionary performance bonus (based upon eligibility). The final salary offered to a successful candidate may vary and will be dependent on several factors that may include but are not limited to: the type and length of experience within the job, the type and length of experience within the industry, skillset, education, business needs, etc. Lupin is a multi-state employer, and this salary range may not reflect positions that work in other states</span></p></div></div><div style="padding:10.0px 0.0px;border:1.0px solid transparent"><div style="font-size:16.0px;word-wrap:break-word"><H2 style="font-size:1.0em;margin:0.0px">Vice President of Commercial, Biosimilars</H2> </div><div><div> <p><strong>Vice President, Commercial – U.S. Biosimilars & 505(b)(2)</strong></p> <p>As Vice President, Commercial – U.S. Biosimilars & 505(b)(2), you will lead the strategic development, launch, and growth of Lupin’s U.S. biosimilars and differentiated 505(b)(2) portfolio. This executive leader will drive market expansion, ensure profitable product positioning, and build commercial excellence across the organization. The role will shape go‑to‑market strategies that accelerate revenue growth, deepen market penetration, and position Lupin as a competitive force in complex and specialty pharmaceutical markets. This position requires a forward‑thinking enterprise builder who can translate deep market insight into strong cross‑functional execution.</p> <p><strong>Key Responsibilities</strong></p> <p><strong>Strategic Commercial Leadership</strong></p> <ul> <li>Own and execute U.S. commercial strategies for biosimilars and 505(b)(2) assets in alignment with enterprise objectives.</li> <li>Lead lifecycle management, pricing strategy, and go‑to‑market planning for pipeline and marketed products.</li> <li>Drive launch readiness, execution, and post‑launch optimization to maximize performance and impact.</li> </ul> <p><strong>Business Development & Portfolio Expansion</strong></p> <ul> <li>Lead commercial diligence and strategic assessments for licensing, partnerships, and portfolio expansion within the biosimilars and 505(b)(2) space.</li> <li>Provide clear market perspectives to inform investment decisions and pipeline prioritization.</li> </ul> <p><strong>Cross‑Functional Collaboration & Market Execution</strong></p> <ul> <li>Partner closely with Regulatory, R&D, Manufacturing, Supply Chain, Medical Affairs, Finance, and Market Access teams to ensure seamless execution from development through launch.</li> <li>Build strong relationships with payers, GPOs, specialty pharmacies, providers, and channel partners to optimize access, reimbursement, and utilization.</li> </ul> <p><strong>Team Leadership</strong></p> <ul> <li>Build and lead a high‑performing commercial organization focused on accountability, collaboration, and sustainable growth.</li> </ul> </div></div></div><div style="padding:10.0px 0.0px;border:1.0px solid transparent"><div style="font-size:16.0px;word-wrap:break-word"><H2 style="font-size:1.0em;margin:0.0px">Competencies</H2> </div><div><div>Collaboration</div><div>Customer Centricity</div><div>Developing Talent</div><div>Innovation & Creativity</div><div>Process Excellence</div><div>Result Orientation</div><div>Stakeholder Management</div><div>Strategic Agility</div></div></div></div>